Ricciuti B.; Lamberti G.; Puchala S.R.; Mahadevan N.R.; Lin J.-R.; Alessi J.V.; Chowdhury A.; Li Y.Y.; Wang X.; Spurr L.; Pecci F.; Di Federico A.; Venkatraman D.; Barrichello A.P.; Gandhi M.; Vaz V.R.; Pangilinan A.J.; Haradon D.; Lee E.; Gupta H.; Pfaff K.L.; Welsh E.L.; Nishino M.; Cherniack A.D.; Johnson B.E.; Weirather J.L.; Dryg I.D.; Rodig S.J.; Sholl L.M.; Sorger P.; Santagata S.; Umeton R.; Awad M.M., Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non-Small-Cell Lung Cancer, «JOURNAL OF CLINICAL ONCOLOGY», 2024, 42, pp. 1311 - 1321 [Scientific article]Open Access
Di Federico, A.; Alden, S. L.; Smithy, J. W.; Ricciuti, B.; Alessi, J. V.; Wang, X.; Pecci, F.; Lamberti, G.; Gandhi, M. M.; Vaz, V. R.; Spurr, L. F.; Sholl, L. M.; Pfaff, K. L.; Rodig, S. J.; Li, Y. Y.; Cherniack, A. D.; Nishino, M.; Johnson, B. E.; Awad, M. M., Intrapatient variation in PD-L1 expression and tumor mutational burden and the impact on outcomes to immune checkpoint inhibitor therapy in patients with non-small-cell lung cancer, «ANNALS OF ONCOLOGY», 2024, 35, pp. 1 - 902 [Scientific article]
Bonazzi, Norma; Fortunati, Emilia; Zanoni, Lucia; Argalia, Giulia; Calabrò, Diletta; Tabacchi, Elena; Allegri, Vincenzo; Campana, Davide; Andrini, Elisa; Lamberti, Giuseppe; Di Franco, Martina; Casadei, Riccardo; Ricci, Claudio; Mosconi, Cristina; Fanti, Stefano; Ambrosini, Valentina, Real-Life Use of [68Ga]Ga-DOTANOC PET/CT in Confirmed and Suspected NETs from a Prospective 5-Year Electronic Archive at an ENETS Center of Excellence: More Than 2000 Scans in More Than 1500 Patients, «CANCERS», 2024, 16, Article number: 701 , pp. 1 - 13 [Scientific article]Open Access
Fletcher K.; Cortellini A.; Ganta T.; Kankaria R.; Song H.; Ye F.; Irlmeier R.; Debnath N.; Saeed A.; Radford M.; Alahmadi A.; Diamond A.; Hoimes C.; Presley C.J.; Owen D.H.; Abou Alaiwi S.; Nassar A.H.; Lamberti G.; Perrone F.; Buti S.; Giusti R.; Filetti M.; Vanella V.; Mallardo D.; Sussman T.A.; Galetta D.; Kalofonou F.; Daniels E.; Ascierto P.A.; Pinato D.J.; Nebhan C.; Berg S.; Choueiri T.K.; Marron T.U.; Wang Y.; Naqash A.R.; Johnson D.B., Safety and efficacy outcomes of early cessation of anti-PD1 therapy in patients 80 years or older: A retrospective cohort study, «CANCER LETTERS», 2024, 596, Article number: 217001 , pp. 1 - 5 [Scientific article]Open Access
Panzuto F.; Andrini E.; Lamberti G.; Pusceddu S.; Rinzivillo M.; Gelsomino F.; Raimondi A.; Bongiovanni A.; Davi M.V.; Cives M.; Brizzi M.P.; Persano I.; Zatelli M.C.; Puliafito I.; Tafuto S.; Campana D., Sequencing Treatments in Patients with Advanced Well-Differentiated Pancreatic Neuroendocrine Tumor (pNET): Results from a Large Multicenter Italian Cohort, «JOURNAL OF CLINICAL MEDICINE», 2024, 13, Article number: 2074 , pp. 1 - 14 [Scientific article]Open Access
Vasileva-Slaveva M.; Morales-Espinosa D.; Puccini A.; Meissner M.; Milic M.; Lamberti G.; Altena R., Tackling hurdles in front of young clinical investigators in oncology – Results from an international survey, «EUROPEAN JOURNAL OF SURGICAL ONCOLOGY», 2024, 50, Article number: 108031 , pp. 1 - 7 [Scientific article]
Wang X.; Lamberti G.; Di Federico A.; Alessi J.; Ferrara R.; Sholl M.L.; Awad M.M.; Vokes N.; Ricciuti B., Tumor mutational burden for the prediction of PD-(L)1 blockade efficacy in cancer: challenges and opportunities, «ANNALS OF ONCOLOGY», 2024, 35, pp. 508 - 522 [Scientific article]
Di Franco M.; Fortunati E.; Zanoni L.; Bonazzi N.; Mosconi C.; Malizia C.; Civollani S.; Campana D.; Andrini E.; Lamberti G.; Allegri V.; Fanti S.; Ambrosini V., β1600 Q.Clear Digital Reconstruction of [68Ga]Ga-DOTANOC PET/CT Improves Image Quality in NET Patients, «JOURNAL OF CLINICAL MEDICINE», 2024, 13, Article number: 3841 , pp. 1 - 10 [Scientific article]Open Access
Andrini E.; Lamberti G.; Alberici L.; Ricci C.; Campana D., An Update on Appendiceal Neuroendocrine Tumors, «CURRENT TREATMENT OPTIONS IN ONCOLOGY», 2023, 24, pp. 742 - 756 [Scientific article]Open Access
Ricci, Claudio; Campana, Davide; Ingaldi, Carlo; Lamberti, Giuseppe; Alberici, Laura; Tateo, Valentina; Castagna, Giovanni; Ricco, Gianluca; Calderaro, Fulvio; Malvi, Deborah; Rosini, Francesca; Casadei, Riccardo, Appendiceal goblet cell carcinoma has marginal advantages from perioperative chemotherapy: a population-based study with an entropy balancing analysis, «LANGENBECK'S ARCHIVES OF SURGERY», 2023, 408, Article number: 65 , pp. 1 - 7 [Scientific article]Open Access
Ricco G.; Seminerio R.; Andrini E.; Malvi D.; Gruppioni E.; Altimari A.; Zagnoni S.; Campana D.; Lamberti G., BRAF V600E-mutated large cell neuroendocrine carcinoma responding to targeted therapy: A case report and review of the literature, «ANTI-CANCER DRUGS», 2023, 34, pp. 1076 - 1084 [Scientific article]
Arianna Zappi; irene persano; Linda Galvani; Elena Parlagreco; Elisa Andrini; Davide Campana; Maria Pia Brizzi; Giuseppe Lamberti; ANNA LA SALVIA, Chemotherapy in Well Differentiated Neuroendocrine Tumors (NET) G1, G2, and G3: A Narrative Review, «JOURNAL OF CLINICAL MEDICINE», 2023, 12, Article number: 717 , pp. 1 - 19 [Scientific article]Open Access
Thummalapalli R.; Ricciuti B.; Bandlamudi C.; Muldoon D.; Rizvi H.; Elkrief A.; Luo J.; Alessi J.V.; Pecci F.; Lamberti G.; Di Federico A.; Hong L.; Zhang J.; Heymach J.V.; Gibbons D.L.; Plodkowski A.J.; Ravichandran V.; Donoghue M.T.A.; Vanderbilt C.; Ladanyi M.; Rudin C.M.; Kris M.G.; Riely G.J.; Chaft J.E.; Hellmann M.D.; Vokes N.I.; Awad M.M.; Schoenfeld A.J., Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer, «CLINICAL CANCER RESEARCH», 2023, 29, pp. 4408 - 4418 [Scientific article]Open Access
Alessi J.V.; Elkrief A.; Ricciuti B.; Wang X.; Cortellini A.; Vaz V.R.; Lamberti G.; Frias R.L.; Venkatraman D.; Fulgenzi C.A.M.; Pecci F.; Recondo G.; Di Federico A.; Barrichello A.; Park H.; Nishino M.; Hambelton G.M.; Egger J.V.; Ladanyi M.; Digumarthy S.; Johnson B.E.; Christiani D.C.; Lin X.; Gainor J.F.; Lin J.J.; Pinato D.J.; Schoenfeld A.J.; Awad M.M., Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLC, «JOURNAL OF THORACIC ONCOLOGY», 2023, 18, pp. 731 - 743 [Scientific article]
Scalera S.; Ricciuti B.; Mazzotta M.; Calonaci N.; Alessi J.V.; Cipriani L.; Bon G.; Messina B.; Lamberti G.; Di Federico A.; Pecci F.; Milite S.; Krasniqi E.; Barba M.; Vici P.; Vecchione A.; De Nicola F.; Ciuffreda L.; Goeman F.; Fanciulli M.; Buglioni S.; Pescarmona E.; Sharma B.; Felt K.D.; Lindsay J.; Rodig S.J.; De Maria R.; Caravagna G.; Cappuzzo F.; Ciliberto G.; Awad M.M.; Maugeri-Sacca M., Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinoma, «ANNALS OF ONCOLOGY», 2023, 34, pp. 275 - 288 [Scientific article]
